Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCadence Mineral Regulatory News (KDNC)

Share Price Information for Cadence Mineral (KDNC)

Share Price is delayed by 15 minutes
Get Live Data
7.65    0.40 (5.52%)
Bid:
7.30
Ask:
8.00
Spread: 0.70 (9.589%)
Market Cap: £31.31m
KDNC Live PriceLast checked at - London Stock Exchange

Intraday Cadence Mineral Share Chart

Corporate Update - Evergreen Lithium

14 Mar 2024 09:18

RNS Number : 8637G
Cadence Minerals PLC
14 March 2024
 

Cadence Minerals Plc

 

("Cadence Minerals", "Cadence", or "the Company")

 

Corporate Update - Evergreen Lithium (ASX: EG1) Uncovers Additional Large Pegmatite Targets in Central-West Bynoe

 

 

Cadence Minerals (AIM: KDNC; OTC: KDNCY) is pleased to note that ASX listed Evergreen Lithium Limited ("Evergreen") (ASX: EG1) has announced that it has received subsequent assays from its Phase 3 geochemical soil sampling at Bynoe in the Northern Territory, identifying additional large lithium targets. These new targets are in the central area of the tenement further demonstrating the potential for additional lithium spodumene mineralisation in the Bynoe pegmatite field, and within EverGreen's 231 square Kilometers of tenure.

 

Highlights:

· EverGreen's Phase 3 Geochemical sampling continues to yield additional large geochemical anomalies at Central Bynoe.

· Assay results from 1,214 samples received reflect similar large-scale lithium trends to those previously identified.

· 3 large new lithium pegmatite prospects have been identified.

· Assays for a further 900 samples are expected to be received shortly.

· Planned work programs for 2024 (dry season) include auger, RAB/AC and RC drilling testing geochemical and geophysical anomalies with potential follow-up diamond drilling.

 

Exploration at Evergreen's Bynoe Project has focused on the discovery of economic lithium mineralisation hosted in lithium-bearing lithium-cesium-tantalum (LCT) pegmatites.

 

Link here to view the full Evergreen ASX announcement

 

Evergreen Exploration Manager Andrew Harwood commented: ""These soil results add to the potential of EverGreen identifying an economic LCT pegmatite discovery at the company's Bynoe Project. Using a variety of proven exploration tools, the team is looking forward to the upcoming dry season to recommence field activities targeting the anomalies outlined by the soils program, the ANT geophysical work, and recent field mapping."

 

Background to Cadence's investment in Evergreen Lithium

 

Cadence Minerals received approximately 15.8 million shares in Evergreen in July 2022 when Cadence sold its 31.5% stake in Lithium Technologies and Lithium Supplies ("LT and LS") to Evergreen as announced on 27 June 2022. A further AS$ 3.47 million (£1.86 million) of shares in Evergreen are due to Cadence on the achievement of certain performance milestones by Evergreen. The pricing of Evergreen shares associated with this consideration is based on a defined pricing mechanism linked to the VWAP and the date at which the performance milestones are achieved. Further details of these milestones can be found in the Evergreen prospectus available here . Cadence's shares are subject to a 2-year escrow agreement as determined by the listing rules of the ASX.

 

 

For further information contact:

 

Cadence Minerals plc

+44 (0) 20 3582 6636

Andrew Suckling

Kiran Morzaria

WH Ireland Limited (NOMAD & Broker)

+44 (0) 20 7220 1666

James Joyce

Darshan Patel

Fortified Securities - Joint Broker

+44 (0) 20 3411 7773

Guy Wheatley

Brand Communications

+44 (0) 7976 431608

Public & Investor Relations

Alan Green

 

Qualified Person

Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information contained in this announcement. Kiran holds a Bachelor of Engineering (Industrial Geology) from the Camborne School of Mines and an MBA (Finance) from CASS Business School.

 

Cautionary and Forward-Looking Statements

Certain statements in this announcement are or may be deemed to be forward-looking statements. Forward-looking statements are identi?ed by their use of terms and phrases such as "believe", "could", "should", "envisage", "estimate", "intend", "may", "plan", "will", or the negative of those variations or comparable expressions including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the company's future growth results of operations performance, future capital, and other expenditures (including the amount, nature, and sources of funding thereof) competitive advantages business prospects and opportunities. Such forward-looking statements re?ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. Many factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes actions by governmental authorities, the availability of capital markets reliance on key personnel uninsured and underinsured losses and other factors many of which are beyond the control of the company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions. The company cannot assure investors that actual results will be consistent with such forward-looking statements.

 

The information contained within this announcement is deemed by the company to constitute Inside Information as stipulated under the Market Abuse Regulation (E.U.) No. 596/2014, as it forms part of U.K. domestic law under the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGCGDXLBBDGSS
Date   Source Headline
28th May 202611:15 amRNSAzteca Restart Update
19th May 20268:44 amRNSHolding(s) in Company
7th May 202610:36 amRNS-RCEO Interview on grant of Installation License
6th May 20265:32 pmRNSIssue of Options
5th May 20267:00 amRNSAmapá – Installation Licence Granted
2nd Apr 20268:00 amRNS-RInvestor Presentation via Investor Meet Company
2nd Apr 20267:05 amRNSIssue of shares to EBT and Total Voting Rights
2nd Apr 20267:00 amRNSAmapá Project Update - Licensing and Azteca
25th Mar 20267:00 amRNSSonora Lithium Project Arbitration Funding
13th Mar 20267:06 amRNSAmapá Project Update
13th Mar 20267:06 amRNSAmapá Project Update
9th Jan 202610:35 amRNS-RInvestor Presentation via Investor Meet Company
7th Jan 202610:32 amRNS-RCEO Interview on Amapá & Azteca Plant
6th Jan 20267:00 amRNSGrant of Preliminary Environmental Licence - Amapá
15th Dec 20257:00 amRNSAmapá Project Update
12th Dec 20257:00 amRNSAmapá Project Update
1st Dec 20257:00 amRNSExecution of Binding Prepayment Offtake Agreement
17th Nov 202511:09 amRNSUpdate on Offtake Financing for the Azteca Plant
6th Oct 20257:00 amRNSResult of Oversubscribed WRAP Retail Offer
3rd Oct 20251:41 pmRNSEarly Close of WRAP Retail Offer
2nd Oct 20257:00 amRNSWRAP Retail Offer for up to £200,000
30th Sep 20257:00 amRNSFunding Secured for Azteca Offtake Agreement
29th Sep 202511:38 amRNSInterim Results for six months ended 30 June 2025
29th Sep 202510:51 amRNSResult of General Meeting
12th Sep 202511:49 amRNSNotice of GM
10th Sep 20258:08 amRNS-RCEO interview on Funding & Azteca/Amapá Production
9th Sep 20257:00 amRNSCadence Signs Terms to Restart Azteca Plant
18th Aug 20257:00 amRNSSignificant Mining Cost Reduction at Amapá Project
6th Aug 20253:19 pmRNSResult of AGM
10th Jul 20252:42 pmRNSNotice of AGM
9th Jul 20252:45 pmRNSCorp Update - EG1 commences exploration at Leonora
8th Jul 202510:31 amRNSAdmission of Shares
1st Jul 20258:29 amRNS-RCEO Interview Regarding Amapa Developments
27th Jun 20251:36 pmRNSDirector Share Purchases
27th Jun 20257:00 amRNSAmapa Production Plan & Equity Subscription
18th Jun 20253:13 pmRNSAnnual Results for the year ended 31 December 2024
10th Jun 202511:59 amRNSAmapa Iron Ore Project Update
7th May 20254:33 pmRNSCorporate Update–retraction to EG1 acquire Leonora
6th May 20257:00 amRNSCorporate Update - EG1 acquires Leonora Goldfields
17th Jan 20258:47 amRNSIssue of Options
15th Jan 202510:24 amRNSEverGreen: LCT Pegmatite & Gold at Bynoe Project
17th Dec 20247:00 amRNSLOI to acquire Projects, £1m Fundraise & Updates
3rd Dec 20247:00 amRNSUpdated PFS Economic Study Delivers Increased NPV
26th Nov 20247:00 amRNSAmapa Iron Ore Project Update
18th Nov 20247:00 amRNSEverGreen – RC Drilling Commenced at Bynoe Project
29th Oct 20249:07 amRNSEverGreen – Spodumene Discovery at Bynoe Project
18th Oct 20242:55 pmRNSResults of AGM
17th Oct 20248:07 amRNSCorporate Update
27th Sep 20247:00 amRNSInterim Results
17th Sep 20247:00 amRNSAmapá Project Licensing on Schedule

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.